Dr. O’Connell is a board-certified Miami cosmetic and medical dermatologist who specializes in the health and beauty of his patients’ skin. He graduated Summa Cum Laude and Phi Beta Kappa with a bachelor’s degree at Vanderbilt University. He received his medical degree from the University of Miami Miller School of Medicine.

Read full bio on Momcurls.com

Dr. O’Connell’s Professional Accomplishments

Publications and Presentations

  • Nouri K, O’Connell C, Rivas M. “Imiquimod in the Treatment of Bowen’s Disease and Invasive Squamous Cell Carcinoma.” Journal of Drugs in Dermatology 2003: 2(6); 669-673.
  • Nouri K, O’Connell C, Alonso A, Rivas M, Alonso Y. “The Miami Special: An Efficient Tool for Mounting Specimens in Mohs Surgery.” J Drugs in Dermatol March 2004; 3(2):175-177.
  • O’Connell C, Wilentz S, Buchholz R . “Aquired Zinc Deficiency: Case Report and Review of Literature” presented at the Caribbean Dermatology Symposium January 2007.
  • O’Connell C. “X-Linked Ichthyosis.” Accepted for live patient live patient viewing and presentation, American Academy of Dermatology summer meeting, 2007.
  • O’Connell C. “Scleroderma”. Accepted for live patient viewing and presentation, American Academy of Dermatology summer meeting, 2007.
  • O’ Connell C, Oranje A, Van Gysel D, Silverberg NB. “Congenital Molluscum Contagiosum: Report of Four Cases and Review of the Literature”. Pediatric Dermatology 2008; 25(5): 553-556.
  • Brandt F, O’Connell C, Cazzaniga A, Waugh JM: Efficacy and Safety Evaluation of a Novel Botulinum Toxin Topical Gel for the Treatment of Moderate to Severe Lateral Canthal Lines. Dermatol Surg; 2010 Dec; 36 Suppl 4:2111-8.
  • O’Connell C. American Academy of Dermatology. Filler Choices. Oral presentation. 2012. San Diego, CA.

Clinical Studies as Sub Investigator

  • A phase 3, multi center, long term, repeat-treatment, open label, single arm trial to demonstrate the safety of repeat treatment with PurTox for the treatment of glabellar rhytides (frown lines). 2009.
  • A phase 2, double-blind, randomized, parallel-group, controlled, dose-ranging, multi-center study to evaluate the safety and efficacy of rt001, a botulinum toxin type a topical gel, for the treatment of moderate to severe lateral canthal lines in adults. Feb 2009.
  • A post approval, multicenter, open-label, longitudinal, uncontrolled study of cosmetic tissue augmentation product (CTA) in the treatment of nasolabial folds in people of color. Feb 2009.
  • A phase 2, double-blind, randomized, parallel-group, controlled, repeat dose, single center study to evaluate the efficacy and safety of rt001, a botulinum toxin type a topical gel, for the treatment of moderate to severe lateral canthal lines in adults. Aug 2009.
  • A pivotal, USA, randomized, evaluator-blinded, active-controlled, multi-center, parallel group comparison study of lsir versus JUVÉDERM® Ultra in the treatment of moderate to severe facial folds and wrinkles. Nov 2009.
  • Post marketing study to evaluate alternative treatment regimens for improvement of wrinkles, skin tone and skin texture of the face. Nov 2009.
  • A randomized, evaluator-blinded, no-treatment-controlled study of the effectiveness and safety of Restylane® in the augmentation of soft tissue fullness of the lips. 2010.
  • An open label study of the safety of Restylane® and Perlane® in the correction of peri-oral wrinkles. 2010.
  • A phase 2, double-blind, randomized, parallel-group, controlled, repeat dose, single center study to evaluate the efficacy and safety of RT001, a botulinum toxin type a topical gel, for the treatment of moderate to severe lateral canthal lines in adults. 2010.
  • A phase 2, double blind, randomized, 4-arm, controlled, multicenter study to evaluate the efficacy and safety of a single dose of RT001 topical gel for the treatment of moderate to severe lateral canthal lines in adults. 2010.
  • A pivotal, USA, randomized, evaluator-blinded, active-controlled, multicenter, split face comparison study of Emervel Classic Lidocaine versus JUVÉDERM Ultra in the treatment of moderate to severe facial wrinkles and folds. 2010.
  • A controlled, randomized, double blind, within-subject, multi-center, prospective clinical trial (pivotal study) of Teosyal® PureSense Global Action vs JUVÉDERM® Ultra XC and Teosyal® PureSense Deep Lines and Ultra Deep vs JUVÉDERM® Ultra Plus XC in the treatment of severe to moderate facial wrinkles such as nasolabial folds. 2011.
  • A randomized, evaluator-blinded, no treatment controlled study of the effectiveness and safety of Perlane-L in the correction of mid-face volume deficit and/or mid-face contour deficiency. 2012.
  • A randomized, evaluator blinded, no treatment controlled study of the effectiveness and safety of small particle hyaluronic acid plus lidocaine (SPHAL) in the augmentation of soft tissue fullness of the lips. 2012.